Olanzapine Tablet
Product Images NDC 13668-170
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 13668-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Fa37d6c9 F803 4efc 8789 4095824eb63e 02)
Tpl Logo (Fa37d6c9 F803 4efc 8789 4095824eb63e 03)
2.5 mg, Tablet (Fa37d6c9 F803 4efc 8789 4095824eb63e 04)
5 mg, Tablet (Fa37d6c9 F803 4efc 8789 4095824eb63e 05)
7.5 mg, Tablet (Fa37d6c9 F803 4efc 8789 4095824eb63e 06)
10 mg, Tablet (Fa37d6c9 F803 4efc 8789 4095824eb63e 07)
15 mg, Tablet (Fa37d6c9 F803 4efc 8789 4095824eb63e 08)
20 mg, Tablet (Fa37d6c9 F803 4efc 8789 4095824eb63e 09)
5 mg Orally Disintegrating Tablets (Fa37d6c9 F803 4efc 8789 4095824eb63e 10)
10 mg, Orally Disintegrating Tablets (Fa37d6c9 F803 4efc 8789 4095824eb63e 11)
15 mg, Orally Disintegrating Tablets (Fa37d6c9 F803 4efc 8789 4095824eb63e 12)
20 mg,orally Disintegrating Tablets (Fa37d6c9 F803 4efc 8789 4095824eb63e 13)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.